
Wellness Goals · Digestive and immune condition
Celiac Disease and Gluten-Related Symptoms
Celiac disease (coeliac disease) · also called Celiac disease, coeliac disease, gluten-related symptoms, gluten intolerance, celiac sprue, enfermedad celiaca, intolerancia al gluten
Celiac disease is a chronic digestive and immune disorder in which eating gluten, a protein in wheat, barley and rye, damages the lining of the small intestine. Here is what celiac disease and gluten-related symptoms are, how celiac disease differs from wheat allergy and gluten sensitivity, why testing must come before a gluten-free diet, and what care and complementary claims involve. The gluten-free diet is established care; evidence for probiotics, enzymes and other add-ons is low or insufficient, and diagnosis needs a clinician.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Celiac Disease and Gluten-Related Symptoms
Celiac disease is an immune reaction to gluten that damages the small intestine, and it is different from a wheat allergy or gluten sensitivity. It must be tested for while you still eat gluten, because a gluten-free diet beforehand can hide it. The treatment is a lifelong gluten-free diet planned with a dietitian; probiotics, oats and other add-ons have only low-certainty support, and diagnosis, ongoing symptoms and complications need a clinician.
What celiac disease is
NIDDK says celiac disease is a chronic digestive and immune disorder that damages the small intestine and is triggered by eating foods containing gluten, a protein found naturally in wheat, barley and rye. Experts estimate about 2 million people in the US and about 1 percent of people worldwide have it, and many are undiagnosed. A 2018 meta-analysis found 1.4% by antibody blood tests and 0.7% by biopsy.
It can occur only in people with certain genes (DQ2 or DQ8), but having the genes alone does not mean you have the disease: about 30 percent of people carry them and only about 3 percent of those develop celiac disease (NIDDK).
Gluten-related symptoms and how they overlap
Symptoms vary widely and may come and go. NIDDK lists bloating, chronic diarrhea, constipation, gas, nausea and abdominal pain, and outside the gut, fatigue, joint or bone pain, depression or anxiety, headaches, nerve symptoms and an itchy blistering rash called dermatitis herpetiformis. Digestive symptoms are more common in children than adults. Some people have no symptoms but can still develop complications.
Because many symptoms look like irritable bowel syndrome or lactose intolerance, celiac disease is not diagnosed from symptoms alone. Long-term complications can include osteoporosis, anemia and malnutrition.
How celiac disease differs from wheat allergy and gluten sensitivity
NIDDK says gluten sensitivity may cause similar symptoms such as abdominal pain and tiredness, but does not damage the small intestine. Wheat allergy is a food allergy in which symptoms such as itchy eyes or breathing trouble differ from celiac disease and no long-term gut damage occurs.
Non-celiac gluten sensitivity has no specific biomarker and relies on self-reported symptoms. A 2025 review found that gluten-specific effects largely disappear once FODMAPs and expectation effects are controlled for. About one in ten people report it, so the label is common but its cause is debated.
Why testing must come before a gluten-free diet
Doctors diagnose celiac disease with blood tests for antibodies and biopsies of the small intestine taken during an upper endoscopy. NIDDK and the NHS both say not to start a gluten-free diet before testing, because it can make the results inaccurate. The 2025 European guidelines describe a conditional no-biopsy approach for selected adults with very high antibody levels and testing options for people already on the diet.
The NHS says to be tested if you have persistent unexplained digestive symptoms, unexplained anaemia, constant tiredness, unintentional weight loss, type 1 diabetes, autoimmune thyroid disease or IBS, or a first-degree relative with the disease. The American College of Gastroenterology suggests blood testing for celiac disease in people with IBS and diarrhea.
Established care, in general terms
The treatment is a gluten-free diet for life. NIDDK says it relieves symptoms and heals intestinal damage, and the NHS recommends dietitian referral and an annual review. Many foods are naturally gluten-free, such as meat, fish, fruits, vegetables, rice and potatoes. Gluten can hide in processed foods and cross-contact can make food unsafe. Foods labelled gluten-free must contain less than 20 parts per million of gluten.
Doctors may also check vitamin and mineral levels, bone density, and follow-up antibody tests. The 2025 European guidelines add sections on oats, bone-health screening, nutrition and psychosocial support, and persistent or refractory disease. Choices and any medicines belong with a clinician.
What care and complementary claims involve
The gluten-free diet has the strongest support (high certainty). Strict adherence goes with better quality of life (moderate). Pure gluten-free oats showed no change in symptoms or biopsies (low). Probiotics eased symptoms in small trials (low), while the low-FODMAP diet for persistent symptoms is mentioned in the 2025 guidelines but has no celiac-specific trial that I read (insufficient). For gluten sensitivity and IBS results are mixed, and a gluten-free diet has no proven benefit for people without a gluten problem. A 2025 review says no enzyme or add-on treatment has yet been conclusively proven to replace the diet. See the Health Benefits and Evidence tabs.
At a glance
Traditional uses history, not proof
Studied for research
- Gluten-free diet for diagnosed celiac disease, high certainty
- Strict adherence and dietitian support, moderate certainty
- Pure gluten-free oats, low certainty
- Balanced gluten-free nutrition, vitamin D and calcium for bone health, low certainty
- Probiotics, low certainty
- Low-FODMAP diet for persistent symptoms, insufficient evidence
- Gluten-free diet for gluten sensitivity and IBS, mixed evidence
- Gluten-free diet without a gluten problem, against; enzymes and supplements as a substitute, insufficient
Main compounds
- Gluten
- Probiotics
- Vitamin D
- Calcium
- FODMAPs
Common forms
- Gluten-free diet
- Gluten-free oats
- Oral supplements
- Dietitian-planned meals
Research links: NIDDK: Definition & Facts for Celiac Disease · NIDDK: Diagnosis of Celiac Disease · NIDDK: Eating, Diet, & Nutrition · NHS: Coeliac disease · ESsCD 2025 guidelines, Part 2: management · Safety of oats in celiac disease, meta-analysis 2017 · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Celiac disease (coeliac disease)
- Common names
- Celiac disease (English); Coeliac disease (English (UK)); Celiac sprue, nontropical sprue, gluten-sensitive enteropathy (English); Enfermedad celiaca, celiaquía (Spanish); Intolerancia al gluten (Spanish)
What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Gluten | protein | Protein in wheat, barley and rye that triggers the immune reaction in celiac disease. 24 | Agency summary | |
| Probiotics | live microbes | Studied by mouth for digestive symptoms. 17 | Human data | |
| Vitamin D and calcium | vitamin and mineral | Studied for bone health in malnourished people. 8 | Human data | |
| FODMAPs | fermentable carbohydrates | Proposed to drive symptoms in gluten sensitivity. 4 | Human data |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| How celiac disease develops | NIDDK: celiac disease almost always occurs in people with the DQ2 or DQ8 gene variants and who eat gluten. About 30 percent of people have DQ2 or DQ8, but only about 3 percent of those develop celiac disease. The NHS describes it as an autoimmune condition in which the immune system mistakes substances in gluten for a threat and damages the surface of the small bowel. 27 22 | Agency summary | |
| Celiac disease compared with wheat allergy and gluten sensitivity | NIDDK: gluten sensitivity may cause similar symptoms but does not damage the small intestine; wheat allergy is a food allergy with different symptoms such as itchy eyes or breathing trouble and does not cause long-term gut damage. 24 | Agency summary |
Isolated compounds versus whole extracts
The studies read tested dietary patterns and supplements, not single compounds; whole-food diets (the gluten-free diet) were studied against symptoms and gut healing.
1 high certainty1 moderate certainty2 mixed findings4 low certainty2 not enough evidence1 evidence against
What was looked at
The 11 benefits and uses checked for Celiac Disease and Gluten-Related Symptoms, each with how strong the evidence is. Tap one to open it.
- Gluten-free diet for diagnosed celiac diseaseHigh certainty
- Strict adherence, dietitian support and adherence checksModerate certainty
- Pure gluten-free oatsLow certainty
- Keeping the gluten-free diet nutritionally balancedLow certainty
- Correcting low nutrients: vitamin D, calcium and bone healthLow certainty
- Probiotics by mouthLow certainty
- Low-FODMAP diet when symptoms persist on a gluten-free dietNot enough evidence
- Gluten-free diet for gluten sensitivity without celiac diseaseMixed findings
- Gluten-free diet for irritable bowel syndromeMixed findings
- Gluten-free eating for people without a gluten problemEvidence against
- Gluten-degrading enzymes, herbs and other supplements as a substitute for the dietNot enough evidence
Lab markers tracked in the studies
Celiac antibody blood tests (IgA anti-TG2)Quality of life score (SF-36)Bone mineral density (DXA scan)
What is Celiac Disease and Gluten-Related Symptoms good for?
The dietary and complementary approaches that have been studied for celiac disease and gluten-related symptoms, and how strong the human evidence is for each. These describe what studies found, not advice to use them. The gluten-free diet is established care that a clinician and dietitian guide, and none of these replace the care described in the About tab.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
Gluten-free diet for diagnosed celiac disease
High certaintyFor people with confirmed celiac disease, a strict lifelong gluten-free diet is the established treatment. It relieves symptoms and lets the gut lining heal. It is described here because it is a dietary approach, but it is care that a clinician and dietitian guide, not a self-treatment for symptoms.
5 studiesStrict avoidance of wheat, barley and rye and of cross-contact for li…
Studies, doses and limits
What the trials found
NIDDK and NHS treatment pages; a 2024 meta-analysis of 17 studies (1,010 people) of potential coeliac disease; a meta-analysis of 18 quality-of-life studies in adults; the 2025 European guidelines.
Results
NIDDK says symptoms typically improve and gut damage heals; many people feel better within days to weeks. The NHS says symptoms should improve within weeks, though complete healing can take up to a few years. In potential coeliac disease, 88% of those on a gluten-free diet reported symptom improvement. In adults, the diet improved quality of life but did not fully bring it to the level of people without coeliac disease.
Effect sizes as reported
Symptom improvement 88% (CI 79% to 97%); quality of life mental score +7.37 (CI 1.84 to 12.90)
Why this rating
High, the compiler's rating: every agency and guideline read names it as the treatment and the pooled studies agree on benefit, although no placebo-controlled trial of a diet exists.
Form and dose studied
Strict avoidance of wheat, barley and rye and of cross-contact for life, as described by NIDDK and the NHS. No amounts apply; the diet is planned with a dietitian.
Who was studied
People with diagnosed (usually biopsy-confirmed) celiac disease; children and adults.
Limits
Quality of life does not fully normalise in adults, about 20 percent of people (NIDDK) still have symptoms, and the diet is hard to follow and costs more. Starting it before testing can make tests inaccurate.
Why researchers looked
Gluten triggers the immune reaction that damages the small intestine in celiac disease, so removing it removes the trigger.
Proposed mechanism Established mechanism
Removing gluten stops the abnormal immune reaction that damages the gut lining (NIDDK, NHS description).
A proposed mechanism does not show that the effect happens in people.
Do not start the diet before testing. Packaged gluten-free foods can be higher in fat and sugar, and a poorly planned diet can lack fibre, iron and calcium (NIDDK). Work with a dietitian.
Strict adherence, dietitian support and adherence checks
Moderate certaintyPeople who follow the diet strictly report better quality of life than those who follow it loosely. Health agencies advise working with a dietitian, and a review found that simple self-report or interview questions track lab results about as well as longer tools.
4 studiesDietitian referral, food journals and routine follow-up as described …
Studies, doses and limits
What the trials found
A meta-analysis of 18 studies of adults; a systematic review of adherence tools compared with laboratory tests; NHS and NIDDK pages.
Results
Strict adherers scored higher on the SF-36 mental scale than non-strict adherers (difference 7.70). Interview, self-report and the BIAGI questionnaire did not differ from each other in matching lab results and did better than the Coeliac Dietary Adherence Test. The NHS notes that many people accidentally eat gluten in the first months after diagnosis.
Effect sizes as reported
Strict vs non-strict mental score +7.70 (CI 4.61 to 10.79)
Why this rating
Moderate, the compiler's rating: consistent pooled results, but the adherence data are mostly self-reported and the studies are observational.
Form and dose studied
Dietitian referral, food journals and routine follow-up as described by NIDDK and the NHS; no tool is advised here.
Who was studied
Adults with celiac disease on a gluten-free diet for at least six months.
Limits
Observational links, not proof that better adherence caused better scores. The tools review compared tests with each other, not outcomes.
Why researchers looked
Accidental gluten is common in the first months, and symptoms alone do not always show whether the gut is healing.
Proposed mechanism Hypothesis
Less gluten exposure means less immune activity in the gut (NIDDK description); not tested directly in the studies read.
A proposed mechanism does not show that the effect happens in people.
Persistent symptoms on the diet need a clinician to look for hidden gluten and other causes, not just stricter rules.
Pure gluten-free oats
Low certaintyOats do not contain gluten, but they are often contaminated with it. A review of 28 studies found that pure oats added to a gluten-free diet did not change symptoms or gut findings, and NIDDK says most people with celiac disease can safely eat moderate amounts of oats if they are gluten-free.
4 studiesStudies used pure, uncontaminated oats. No amounts are advised here; …
Studies, doses and limits
What the trials found
A 2017 systematic review and meta-analysis of 28 studies, 661 people in 8 controlled trials (6 randomised), all using pure oats; the 2025 European guidelines; NIDDK and NHS pages.
Results
Oat consumption for 12 months did not affect symptoms (SMD -0.22, CI -0.56 to 0.13), biopsy findings or antibody tests; children and adults did not differ. The NHS adds that a small number of people with coeliac disease may still react to pure oats, and that ordinary oats can be contaminated.
Effect sizes as reported
SMD -0.22 (CI -0.56 to 0.13) for symptoms
Why this rating
Low, as the authors rate it: few studies for many outcomes and limited geographic spread.
Form and dose studied
Studies used pure, uncontaminated oats. No amounts are advised here; NIDDK says to discuss amounts with a doctor or dietitian.
Who was studied
Children and adults with celiac disease in trials; most had stable disease.
Limits
Ordinary oats can carry wheat, barley or rye, and a few people react to pure oats.
Why researchers looked
Oats add fibre and variety to a restricted diet, but their safety was long debated.
Proposed mechanism Hypothesis
Pure oats contain a protein related to gluten, but studies suggest it rarely triggers the same reaction (the sources read do not explain this in detail).
A proposed mechanism does not show that the effect happens in people.
Only buy oats labelled gluten-free, and ask your doctor or dietitian first, especially if symptoms return after adding oats.
Keeping the gluten-free diet nutritionally balanced
Low certaintyA gluten-free diet can fall short on fibre, vitamins and minerals and run high in sugar and fat when it relies on packaged substitutes. Reviews and agencies advise assessing nutrition and building the diet around naturally gluten-free whole foods with a dietitian.
3 studiesNaturally gluten-free whole foods and dietitian-planned meals; no amo…
Studies, doses and limits
What the trials found
A 2024 narrative review in Gastroenterology; NIDDK pages; the 2025 European guidelines mention nutritional support.
Results
The review says the diet can be nutritionally inadequate, is often linked with vitamin and mineral deficiencies, and with too much sugar and fat from substitutes, and links it with higher rates of overweight and obesity. NIDDK lists naturally gluten-free foods (meat, fish, fruits, vegetables, rice, potatoes, and flours such as corn, soy, nuts, quinoa, buckwheat or beans).
Effect sizes as reported
Not given as numbers in the abstract
Why this rating
Low, the compiler's rating: a narrative review and agency advice, with no trial testing a specific approach.
Form and dose studied
Naturally gluten-free whole foods and dietitian-planned meals; no amounts advised here.
Who was studied
People with celiac disease on long-term gluten-free diets.
Limits
Narrative evidence; no trial of a particular menu was read.
Why researchers looked
Many gluten-free substitutes are made from refined starches and can be less nutritious than the foods they replace.
Proposed mechanism Hypothesis
Refined gluten-free flours and added fat and sugar change nutrient intake (review description).
A proposed mechanism does not show that the effect happens in people.
Supplements are only for deficiencies your doctor finds; ask a pharmacist whether any product contains gluten.
Correcting low nutrients: vitamin D, calcium and bone health
Low certaintyUntreated celiac disease can weaken bones. A review found that a gluten-free diet gave partial bone-density recovery within a year and full recovery by year five, and that vitamin D and calcium supplements helped malnourished people. Supplements are for deficiencies a doctor finds, not routine use.
3 studiesSupplement forms and amounts were not described in the abstract and a…
Studies, doses and limits
What the trials found
A 2015 systematic review of 20 studies of newly diagnosed adults followed for at least a year; NIDDK and NHS pages.
Results
Bone density recovered partially by one year and fully by year five on a gluten-free diet in all studies. Supplementation with vitamin D and calcium gave significant improvement in malnourished patients. Evidence for physical activity was limited. NIDDK says doctors may test vitamin and mineral levels and recommend supplements if needed, and may order a bone density test.
Effect sizes as reported
Not given as numbers in the abstract
Why this rating
Low, the compiler's rating: observational studies, a 2015 review, and the supplement finding applies to malnourished people only.
Form and dose studied
Supplement forms and amounts were not described in the abstract and are not advised here; NIDDK says a doctor decides.
Who was studied
Newly diagnosed adults with celiac disease, some malnourished.
Limits
Mostly cohort and case-control studies; only 20 of 207 studies qualified.
Why researchers looked
Damage to the gut lining reduces absorption of calcium, vitamin D and other nutrients.
Proposed mechanism Hypothesis
Healing of the gut lining restores nutrient absorption (NIDDK description); supplements replace what is missing.
A proposed mechanism does not show that the effect happens in people.
Talk with your doctor before taking vitamins or any complementary products (NIDDK). Too much of some nutrients can be harmful, and some products contain gluten.
Probiotics by mouth
Low certaintyTwo meta-analyses of small randomised trials suggest probiotics may ease digestive symptoms and raise helpful gut bacteria in people with celiac disease, without more side effects. The certainty is very low to low.
3 studiesDifferent strains and products were used; the abstracts do not name t…
Studies, doses and limits
What the trials found
A 2020 meta-analysis of 6 randomised trials (279 people) and a 2023 meta-analysis of 14 trials (5 pooled).
Results
Symptoms improved on the Gastrointestinal Symptom Rating Scale (-28.7%, CI -43.96 to -13.52) but not when different questionnaires were pooled. Bifidobacteria and Lactobacillus rose. Side effects did not differ from placebo. Quality of life data were too thin to judge.
Effect sizes as reported
GI Symptom Rating Scale -28.7% (CI -43.96 to -13.52)
Why this rating
Low, in line with the first review (very low to low): few small trials, different products and questionnaires.
Form and dose studied
Different strains and products were used; the abstracts do not name them all. No product is advised here.
Who was studied
People with celiac disease, some with persistent symptoms on a gluten-free diet.
Limits
Small trials, mixed results, overlap between the two reviews, and unknown best strain. Probiotics are not a replacement for the gluten-free diet.
Why researchers looked
Many people still have symptoms on the diet, and the gut bacteria of people with celiac disease differ from others.
Proposed mechanism Hypothesis
Proposed in the reviews: probiotics change gut bacteria and immune responses. Not proven in these trials.
A proposed mechanism does not show that the effect happens in people.
People with weakened immunity should ask a doctor first. Check that a product is labelled gluten-free (NIDDK advises asking a pharmacist about supplement ingredients).
Low-FODMAP diet when symptoms persist on a gluten-free diet
Not enough evidenceThe 2025 European guidelines include a section on low-FODMAP diets for people with persistent symptoms despite a gluten-free diet. I could read only the abstract, so the strength of that advice and the evidence behind it in celiac disease are not stated here.
3 studiesA limited, dietitian-guided trial is how IBS guidance frames it; no d…
Studies, doses and limits
What the trials found
The 2025 European guidelines (abstract); an ACG guideline for IBS recommending a limited low-FODMAP trial in IBS; a 2026 meta-analysis of IBS diets.
Results
The European guideline abstract lists low-FODMAP diets for persistent symptoms as a new or expanded topic. In IBS, the American College of Gastroenterology recommends a limited trial and the 2026 meta-analysis found consistent short-term benefit. No randomised trial in celiac disease was read.
Effect sizes as reported
IBS trials: responder rate 34% to 78% in the low-FODMAP arms
Why this rating
Insufficient for celiac disease specifically: I read only the guideline abstract and IBS evidence, not a celiac-specific trial.
Form and dose studied
A limited, dietitian-guided trial is how IBS guidance frames it; no details are advised here.
Who was studied
People with celiac disease who still have symptoms after the cause has been checked; adults with IBS in the IBS evidence.
Limits
The low-FODMAP diet is restrictive. It can be hard on nutrition and should not delay checking for ongoing gluten exposure or other causes.
Why researchers looked
Some people with celiac disease also have irritable bowel syndrome or other causes of symptoms, and FODMAPs (fermentable carbohydrates) can drive gas and bloating.
Proposed mechanism Hypothesis
FODMAPs ferment in the gut and can cause gas and bloating (general explanation; not tested in the sources read).
A proposed mechanism does not show that the effect happens in people.
Do not use it to avoid testing; persistent symptoms on a gluten-free diet need a clinician to look for hidden gluten and other conditions.
Gluten-free diet for gluten sensitivity without celiac disease
Mixed findingsMany people feel unwell after eating wheat or gluten even though celiac tests are negative. Reviews find that the gluten itself is often not the cause: once fermentable carbohydrates and expectations are controlled for, gluten-specific effects largely disappear. A gluten-free diet here is best a short, supervised trial.
3 studiesA time-limited gluten-free trial supervised by a dietitian, per the 2…
Studies, doses and limits
What the trials found
A 2025 review of gluten-restriction trials; a 2025 review of non-celiac gluten sensitivity; the NIDDK definition page.
Results
Gluten-specific effects were inconsistent and mostly vanished with FODMAP and expectation controls, and meta-analyses show modest, inconsistent relief. NCGS has no specific biomarker and relies on self-reported symptoms. NIDDK states that gluten sensitivity does not damage the small intestine.
Effect sizes as reported
Not given as numbers in the abstracts
Why this rating
Mixed, the compiler's rating: some people feel better, but controlled trials do not isolate gluten as the cause.
Form and dose studied
A time-limited gluten-free trial supervised by a dietitian, per the 2025 review; no amounts apply.
Who was studied
Adults reporting gluten-related symptoms with negative celiac tests.
Limits
Narrative reviews; large nocebo (expectation) responses; no standard diagnostic test.
Why researchers looked
About one in ten people worldwide report gluten or wheat sensitivity, and many follow a gluten-free diet.
Proposed mechanism Hypothesis
Other wheat components (fructans, amylase-trypsin inhibitors, wheat germ agglutinin) and expectation effects may contribute (review proposals).
A proposed mechanism does not show that the effect happens in people.
Get tested for celiac disease before stopping gluten, because avoiding it first can make tests inaccurate.
Gluten-free diet for irritable bowel syndrome
Mixed findingsA 2026 meta-analysis of 10 randomised trials found the gluten-free diet gave inconsistent results in IBS and no clear advantage over other diets. The American College of Gastroenterology suggests testing for celiac disease in IBS with diarrhea.
2 studiesTrial diets as reported; no amounts advised.
Studies, doses and limits
What the trials found
A 2026 systematic review and meta-analysis of 10 randomised trials (939 adults); the 2021 ACG IBS guideline.
Results
The gluten-free diet had a pooled risk ratio of 1.19 (CI 0.83 to 1.70) against comparator diets, which is not a significant advantage. The ACG guideline suggests serologic testing to rule out celiac disease in people with IBS and diarrhea.
Effect sizes as reported
RR 1.19 (95% CI 0.83 to 1.70)
Why this rating
Mixed, the compiler's rating: some trials favour it, the pooled result does not.
Form and dose studied
Trial diets as reported; no amounts advised.
Who was studied
Adults with irritable bowel syndrome.
Limits
Few trials; the abstract of the meta-analysis was cut short in my read.
Why researchers looked
IBS and celiac disease have similar symptoms, so many people with IBS try a gluten-free diet.
Proposed mechanism Hypothesis
Unknown; possible role of FODMAPs rather than gluten (review proposal).
A proposed mechanism does not show that the effect happens in people.
Rule out celiac disease before cutting gluten.
Gluten-free eating for people without a gluten problem
Evidence againstNIDDK says researchers have found no evidence that a gluten-free diet promotes better health or weight loss in the general population. A Cochrane review found no link between lower gluten intake and heart disease and a possible slightly higher risk of type 2 diabetes in low-certainty cohort data.
2 studiesThe reviews compared low and high gluten intake; no amounts are advis…
Studies, doses and limits
What the trials found
A 2022 Cochrane review (1 trial of 60 people and cohorts of about 428,000 adults without celiac disease); NIDDK eating page.
Results
Lower gluten intake was not linked with cardiovascular death (HR 1.00, CI 0.95 to 1.06) or heart attack (HR 0.99, CI 0.89 to 1.10). Lower gluten intake may be linked with a slightly higher risk of type 2 diabetes (HR 1.14, CI 1.07 to 1.22). Certainty was low or very low.
Effect sizes as reported
Type 2 diabetes HR 1.14 (CI 1.07 to 1.22)
Why this rating
Against, the compiler's rating: no health benefit was found and there are possible nutritional downsides, but the cohort evidence is low certainty.
Form and dose studied
The reviews compared low and high gluten intake; no amounts are advised.
Who was studied
Adults in the general population without celiac disease.
Limits
Observational data; people who eat less gluten may differ in other ways.
Why researchers looked
The gluten-free diet is popular as a health choice, which makes it worth checking.
Proposed mechanism Hypothesis
No benefit mechanism for people without gluten-related disease was found in the sources read.
A proposed mechanism does not show that the effect happens in people.
Cutting out gluten on your own can lead to gaps in fibre, iron and calcium (NIDDK) and can hide a celiac diagnosis.
Gluten-degrading enzymes, herbs and other supplements as a substitute for the diet
Not enough evidenceNo enzyme, herb or supplement has been shown to replace the gluten-free diet. A 2025 review of treatments under development says none has yet been conclusively proven to be an effective alternative, and I found no herbal remedy for celiac disease in the sources I read.
2 studiesTrial products are investigational; no product or amount is advised.
Studies, doses and limits
What the trials found
A 2025 review of current and emerging celiac treatments; NIDDK treatment page.
Results
The review lists several approaches in trials and concludes none has been shown to replace the gluten-free diet. NIDDK says to talk with your doctor before using supplements or any complementary or alternative medicines.
Effect sizes as reported
No effect sizes in the abstract
Why this rating
Insufficient: early-stage research, no proven substitute for the diet.
Form and dose studied
Trial products are investigational; no product or amount is advised.
Who was studied
People with celiac disease in early trials.
Limits
Narrative review of early research; some of the products are drugs, which this site does not recommend.
Why researchers looked
The diet is hard to follow, so people look for add-on or replacement treatments.
Proposed mechanism Hypothesis
Enzymes aim to break gluten down and other agents to bind it or protect the gut barrier; still being tested (review description).
A proposed mechanism does not show that the effect happens in people.
Never rely on an enzyme, supplement or herb to "cover" gluten. Many supplements can contain hidden gluten.
Connections to the rest of health
How Celiac Disease and Gluten-Related Symptoms connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Gut Health | High certainty | Gluten-free diet for diagnosed celiac disease: For people with confirmed celiac disease, a strict lifelong gluten-free diet is the established treatment. It relieves symptoms and lets the gut lining heal. It is described here because it is a dietary approach, but it is care that a clinician and dietitian guide, not a self-treatment for symptoms. Keeping the gluten-free diet nutritionally balanced: A gluten-free diet can fall short on fibre, vitamins and minerals and run high in sugar and fat when it relies on packaged substitutes. Reviews and agencies advise assessing nutrition and building the diet around naturally gluten-free whole foods with a dietitian. | 18 5 2 28 23 13 26 9 20 | |
| Digestive Support | High certainty | Gluten-free diet for diagnosed celiac disease: For people with confirmed celiac disease, a strict lifelong gluten-free diet is the established treatment. It relieves symptoms and lets the gut lining heal. It is described here because it is a dietary approach, but it is care that a clinician and dietitian guide, not a self-treatment for symptoms. Keeping the gluten-free diet nutritionally balanced: A gluten-free diet can fall short on fibre, vitamins and minerals and run high in sugar and fat when it relies on packaged substitutes. Reviews and agencies advise assessing nutrition and building the diet around naturally gluten-free whole foods with a dietitian. | 18 5 2 28 23 13 26 9 20 | |
| Gut Health | Moderate certainty | Strict adherence, dietitian support and adherence checks: People who follow the diet strictly report better quality of life than those who follow it loosely. Health agencies advise working with a dietitian, and a review found that simple self-report or interview questions track lab results about as well as longer tools. | 5 15 28 21 | |
| Digestive Support | Moderate certainty | Strict adherence, dietitian support and adherence checks: People who follow the diet strictly report better quality of life than those who follow it loosely. Health agencies advise working with a dietitian, and a review found that simple self-report or interview questions track lab results about as well as longer tools. | 5 15 28 21 | |
| Gut Health | Low certainty | Pure gluten-free oats: Oats do not contain gluten, but they are often contaminated with it. A review of 28 studies found that pure oats added to a gluten-free diet did not change symptoms or gut findings, and NIDDK says most people with celiac disease can safely eat moderate amounts of oats if they are gluten-free. Probiotics by mouth: Two meta-analyses of small randomised trials suggest probiotics may ease digestive symptoms and raise helpful gut bacteria in people with celiac disease, without more side effects. The certainty is very low to low. | 14 2 26 23 17 12 28 | |
| Digestive Support | Low certainty | Pure gluten-free oats: Oats do not contain gluten, but they are often contaminated with it. A review of 28 studies found that pure oats added to a gluten-free diet did not change symptoms or gut findings, and NIDDK says most people with celiac disease can safely eat moderate amounts of oats if they are gluten-free. Probiotics by mouth: Two meta-analyses of small randomised trials suggest probiotics may ease digestive symptoms and raise helpful gut bacteria in people with celiac disease, without more side effects. The certainty is very low to low. | 14 2 26 23 17 12 28 | |
| Gut Health | Low certainty | Correcting low nutrients: vitamin D, calcium and bone health: Untreated celiac disease can weaken bones. A review found that a gluten-free diet gave partial bone-density recovery within a year and full recovery by year five, and that vitamin D and calcium supplements helped malnourished people. Supplements are for deficiencies a doctor finds, not routine use. | 8 28 21 | |
| Digestive Support | Low certainty | Correcting low nutrients: vitamin D, calcium and bone health: Untreated celiac disease can weaken bones. A review found that a gluten-free diet gave partial bone-density recovery within a year and full recovery by year five, and that vitamin D and calcium supplements helped malnourished people. Supplements are for deficiencies a doctor finds, not routine use. | 8 28 21 | |
| Gut Health | Mixed findings | Gluten-free diet for gluten sensitivity without celiac disease: Many people feel unwell after eating wheat or gluten even though celiac tests are negative. Reviews find that the gluten itself is often not the cause: once fermentable carbohydrates and expectations are controlled for, gluten-specific effects largely disappear. A gluten-free diet here is best a short, supervised trial. Gluten-free diet for irritable bowel syndrome: A 2026 meta-analysis of 10 randomised trials found the gluten-free diet gave inconsistent results in IBS and no clear advantage over other diets. The American College of Gastroenterology suggests testing for celiac disease in IBS with diarrhea. | 4 3 24 20 9 | |
| Digestive Support | Mixed findings | Gluten-free diet for gluten sensitivity without celiac disease: Many people feel unwell after eating wheat or gluten even though celiac tests are negative. Reviews find that the gluten itself is often not the cause: once fermentable carbohydrates and expectations are controlled for, gluten-specific effects largely disappear. A gluten-free diet here is best a short, supervised trial. Gluten-free diet for irritable bowel syndrome: A 2026 meta-analysis of 10 randomised trials found the gluten-free diet gave inconsistent results in IBS and no clear advantage over other diets. The American College of Gastroenterology suggests testing for celiac disease in IBS with diarrhea. | 4 3 24 20 9 | |
| Gut Health | Evidence against | Gluten-free eating for people without a gluten problem: NIDDK says researchers have found no evidence that a gluten-free diet promotes better health or weight loss in the general population. A Cochrane review found no link between lower gluten intake and heart disease and a possible slightly higher risk of type 2 diabetes in low-certainty cohort data. | 16 26 | |
| Digestive Support | Evidence against | Gluten-free eating for people without a gluten problem: NIDDK says researchers have found no evidence that a gluten-free diet promotes better health or weight loss in the general population. A Cochrane review found no link between lower gluten intake and heart disease and a possible slightly higher risk of type 2 diabetes in low-certainty cohort data. | 16 26 | |
| Gut Health | Not enough evidence | Gluten-degrading enzymes, herbs and other supplements as a substitute for the diet: No enzyme, herb or supplement has been shown to replace the gluten-free diet. A 2025 review of treatments under development says none has yet been conclusively proven to be an effective alternative, and I found no herbal remedy for celiac disease in the sources I read. | 7 28 | |
| Digestive Support | Not enough evidence | Gluten-degrading enzymes, herbs and other supplements as a substitute for the diet: No enzyme, herb or supplement has been shown to replace the gluten-free diet. A 2025 review of treatments under development says none has yet been conclusively proven to be an effective alternative, and I found no herbal remedy for celiac disease in the sources I read. | 7 28 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Digestive System | Biological association | High certainty | Studied for: Gluten-free diet for diagnosed celiac disease Studied for: Strict adherence, dietitian support and adherence checks | 18 5 2 28 23 15 21 14 26 13 17 12 9 20 4 3 24 7 |
| Metabolism Weight | Biological association | Low certainty | Studied for: Keeping the gluten-free diet nutritionally balanced | 13 26 2 |
| Musculoskeletal System | Biological association | Low certainty | Studied for: Correcting low nutrients: vitamin D, calcium and bone health | 8 28 21 |
| Cardiovascular System | Biological association | Evidence against | Studied for: Gluten-free eating for people without a gluten problem | 16 26 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Celiac antibody blood tests (IgA anti-TG2) | Biological association | Moderate certainty | Measured in trials: typically return to normal after treatment (NIDDK). A lab change is not the same as a health benefit. | 28 21 1 |
| Quality of life score (SF-36) | Biological association | Moderate certainty | Measured in trials: rose on a gluten-free diet, but stayed below non-coeliac controls. A lab change is not the same as a health benefit. | 5 |
| Bone mineral density (DXA scan) | Biological association | Low certainty | Measured in trials: partly recovered by one year and fully by year five on a gluten-free diet. A lab change is not the same as a health benefit. | 8 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Gluten | Biological association | Agency summary | Protein in wheat, barley and rye that triggers the immune reaction in celiac disease. | 24 |
| Probiotics | Biological association | Human | Studied by mouth for digestive symptoms. | 17 |
| Vitamin D and calcium | Biological association | Human | Studied for bone health in malnourished people. | 8 |
| FODMAPs | Biological association | Human | Proposed to drive symptoms in gluten sensitivity. | 4 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 31, 2026).
Evidence at a glance: what the research found for 11 outcomes
Each outcome below is one thing researchers measured. Certainty is how far the evidence can be trusted, not how well it works. The full studies are on the next tab.
The evidence
The research centre for Celiac Disease and Gluten-Related Symptoms. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, read the abstract of every review and guideline cited, and read the NIDDK and NHS pages as plain text. Certainty ratings are the compiler's own reading unless a review gives its own grade.
Study library: every study we checked 28
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Al-Toma 2025 European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach United European Gastroenterol J · PMID 40999951 · DOI |
Clinical guideline |
Adults with suspected coeliac disease (European panel of experts) | Diagnostic approach (blood tests, biopsy, genetic typing) · vs Varies by recommendation |
Part 1 of the 2025 European guidelines. It describes a conditional no-biopsy approach for selected adults with a very high IgA anti-TG2 antibody level, at least four duodenal biopsy samples otherwise, and HLA-DQ2/DQ8 typing in select cases. It also gives approaches for people already on a gluten-free diet. Not given as numbers in the abstract Methods, limits and fundingOutcomes: Guidance on diagnosis, including diagnosis in people already on a gluten-free diet Limitations: Only the abstract was read; the full recommendations were not. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Al-Toma 2026 European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses United European Gastroenterol J · PMID 41831197 · DOI |
Clinical guideline |
Adults with coeliac disease (European panel of experts) | Management, follow-up and care of complex disease courses · vs Varies by recommendation |
Part 2 of the 2025 European Society for the Study of Coeliac Disease guidelines. New or expanded sections cover safe inclusion of oats, low-FODMAP diets in people with persistent symptoms, exocrine pancreatic insufficiency, functional asplenia and vaccination, stratified bone-health screening, nutritional and psychosocial support, and refractory disease. Not given as numbers in the abstract Methods, limits and fundingOutcomes: Guidance on diet, oats, low-FODMAP diets for persistent symptoms, bone-health screening, nutritional and psychosocial support, follow-up and refractory disease Limitations: Only the abstract was read, so the individual recommendations and their strength are not stated here. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Bektaş 2025 Non-celiac Gluten Sensitivity: A New Clinical Entity or Growing Controversy? Euroasian J Hepatogastroenterol · PMID 41757144 · DOI |
Narrative review |
Non-celiac gluten sensitivity (NCGS) literature | Gluten-containing foods and wheat components · vs Gluten-free or low-FODMAP diets |
NCGS has no specific biomarker and relies on self-reported symptoms. Other wheat components (amylase-trypsin inhibitors, wheat germ agglutinin, fructans) may contribute, so "non-celiac wheat sensitivity" is increasingly preferred. Low-FODMAP diets can ease symptoms attributed to NCGS. The author warns that unneeded gluten-free diets may cause nutritional imbalance. Narrative review; no pooled numbers in the abstract Methods, limits and fundingOutcomes: Diagnosis and triggers of NCGS Limitations: A short narrative review, not a systematic search. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Biesiekierski 2025 Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity Best Pract Res Clin Gastroenterol · PMID 41423308 · DOI |
Narrative review |
Gluten-challenge studies and meta-analyses outside celiac disease | Gluten-free diet / gluten challenge · vs Placebo or FODMAP-controlled challenge |
Across trials, reproducible gluten-specific effects largely disappear once FODMAPs and expectation effects are controlled for, and meta-analyses report only modest, inconsistent symptom relief. The review suggests a gluten-free diet be a last-resort, time-limited probe supervised by a dietitian. Not given as numbers in the abstract Methods, limits and fundingOutcomes: Gluten-specific symptoms in people without celiac disease Limitations: A narrative review; no pooled figures in the abstract. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Burger 2017 Systematic review with meta-analysis: Dietary adherence influences normalization of health-related quality of life in coeliac disease Clin Nutr · PMID 27179800 · DOI |
Systematic review meta analysis |
18 studies (16 pooled) of adults with coeliac disease | Gluten-free diet · vs Before diet or non-coeliac controls |
A gluten-free diet improved quality of life scores, but treated adults still scored lower than non-coeliac controls on the SF-36 physical and mental scores. Strict adherence went with better scores than non-strict adherence. Mental component +7.37 (CI 1.84 to 12.90); physical +5.72 (CI 1.50 to 9.95); strict vs non-strict mental +7.70 (CI 4.61 to 10.79) Methods, limits and fundingOutcomes: Health-related quality of life questionnaires Limitations: Mostly observational comparisons; adherence was largely self-reported. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Clappison 2020 Psychiatric Manifestations of Coeliac Disease, a Systematic Review and Meta-Analysis Nutrients · PMID 31947912 · DOI |
Systematic review meta analysis |
37 articles about people with coeliac disease and mental health conditions | Not an intervention study · vs Healthy controls |
Coeliac disease was linked with higher odds of depression, anxiety, eating disorders, autism spectrum disorder and ADHD. Bipolar disorder and schizophrenia did not differ significantly. The authors say it is unclear what a gluten-free diet does to this link. Anxiety OR 6.03 (CI 2.22 to 16.35); eating disorders OR 1.62 (CI 1.37 to 1.91) Methods, limits and fundingOutcomes: Risk of psychiatric conditions Limitations: An association only; it does not show cause. Some intervals are wide. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Girbal-González 2025 Is There a Future Without Gluten Restrictions for Celiac Patients? Update on Current Treatments Nutrients · PMID 41010485 · DOI |
Narrative review |
Celiac disease treatment research | Gluten-degrading enzymes, gluten binders, gut-barrier drugs, immune therapies, probiotics, nutraceuticals · vs Gluten-free diet |
Despite encouraging early results, no treatment has yet been conclusively proven to be an effective alternative to the gluten-free diet. Narrative review; no pooled numbers in the abstract Methods, limits and fundingOutcomes: Whether any option can replace the gluten-free diet Limitations: A review of mostly early research; it lists drug candidates, which are not recommended here. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Grace-Farfaglia 2015 Bones of contention: bone mineral density recovery in celiac disease--a systematic review Nutrients · PMID 25961322 · DOI |
Systematic review |
20 studies of newly diagnosed adults with celiac disease followed at least a year | Gluten-free diet, supplements, exercise, bisphosphonates · vs Not compared across studies |
A gluten-free diet gave partial recovery of bone density by one year and full recovery by year five. In malnourished people, vitamin D and calcium supplements gave significant improvement. Evidence for physical activity was limited. Not given as numbers in the abstract Methods, limits and fundingOutcomes: Bone mineral density by DXA scan Limitations: Observational designs; only 20 of 207 studies qualified; published 2015. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Lacy 2021 ACG Clinical Guideline: Management of Irritable Bowel Syndrome Am J Gastroenterol · PMID 33315591 · DOI |
Clinical guideline |
Adults with irritable bowel syndrome | IBS diagnosis and management · vs Varies by recommendation |
The American College of Gastroenterology suggests blood testing to rule out celiac disease in people with IBS and diarrhea symptoms, and recommends a limited trial of a low-FODMAP diet for IBS. Not given as numbers in the abstract Methods, limits and fundingOutcomes: Guidance for diagnosing and managing IBS Limitations: About IBS, not celiac disease; relevant because the two overlap. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Lizano-Díez 2021 Gluten in pharmaceutical products: a scoping review Syst Rev · PMID 34364399 · DOI |
Scoping review |
13 initiatives about gluten in medicines | Not an intervention study · vs Not an intervention study |
Labelling and information about gluten in medicines varies widely between countries, and information is still scarce. Not given as numbers in the abstract Methods, limits and fundingOutcomes: Information and labelling about gluten in medicines Limitations: A scoping review; it does not say how often medicines contain meaningful gluten. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Malamut 2024 Advances in Nonresponsive and Refractory Celiac Disease Gastroenterology · PMID 38556189 · DOI |
Narrative review |
People with celiac disease whose symptoms continue despite a gluten-free diet | Diet review, tests for other causes, and specialist treatment · vs Not compared |
Non-responsive celiac disease is relatively common and is generally due to continuing gluten exposure, which resolves when diet errors are corrected. Other complications and look-alike conditions need to be excluded. Refractory celiac disease is rare; one type is a low-grade lymphoma-like condition with a poor outlook. Narrative review; no pooled numbers in the abstract Methods, limits and fundingOutcomes: Causes and management of non-responsive and refractory disease Limitations: A narrative review. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Mozafarybazargany 2023 The effects of probiotics on gastrointestinal symptoms and microbiota in patients with celiac disease: a systematic review and meta-analysis on clinical trials Clin Exp Med · PMID 36609792 · DOI |
Systematic review meta analysis |
14 trials in the review, 5 pooled; people with celiac disease or celiac autoimmunity | Probiotics or synbiotics · vs Placebo |
Probiotics might ease digestive symptoms, especially in people with more symptoms, and raised Bifidobacterium and Lactobacillus levels. They did not increase side effects. The authors say high-quality trials are still needed and the best combination is unknown. Bifidobacterium SMD 0.72 (CI 0.13 to 1.30); Lactobacillus SMD 0.49 (CI 0.18 to 0.80) Methods, limits and fundingOutcomes: Digestive symptoms, immune markers, gut bacteria, side effects Limitations: Small number of pooled trials; inconsistent results; the best strain or combination is unknown. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Pinto-Sanchez 2024 Nutrition Assessment and Management in Celiac Disease Gastroenterology · PMID 38593924 · DOI |
Narrative review |
People with celiac disease on a gluten-free diet | Gluten-free diet · vs Not compared |
A gluten-free diet can be nutritionally inadequate, is often linked with vitamin and mineral deficiencies, and with too much sugar and fat when gluten-free substitutes dominate. The review notes higher rates of overweight and obesity and related problems, and says nutrition status and diet quality should be assessed at diagnosis and on follow-up. Narrative review; no pooled numbers in the abstract Methods, limits and fundingOutcomes: Nutritional adequacy Limitations: A narrative review, not a systematic search. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Pinto-Sánchez 2017 Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies Gastroenterology · PMID 28431885 · DOI |
Systematic review meta analysis |
661 661 people in 8 controlled trials (6 randomised); 28 studies in all, children and adults with celiac disease |
Oats added to a gluten-free diet (all randomised trials used pure, uncontaminated oats) · vs Gluten-free diet without oats |
Oats eaten for 12 months did not change symptoms, biopsy scores, intraepithelial lymphocyte counts or antibody tests. Children and adults did not differ. Symptom score difference SMD -0.22 (95% CI -0.56 to 0.13) Methods, limits and fundingOutcomes: Symptoms, blood antibodies, intestinal biopsy findings Limitations: The authors rate the overall quality of evidence as low: few studies for many outcomes and limited geographic spread. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Ribeiro 2024 Gluten-Free Diet Adherence Tools for Individuals with Celiac Disease: A Systematic Review and Meta-Analysis of Tools Compared to Laboratory Tests Nutrients · PMID 39125309 · DOI |
Systematic review meta analysis |
Adults with celiac disease on a gluten-free diet for at least six months | Questionnaires, self-report and interviews used to judge diet adherence · vs Laboratory checks (antibody tests, gluten immunogenic peptides, biopsy) |
Four tools were compared: the BIAGI score, the Coeliac Dietary Adherence Test, self-report questions and interviews. Interview, self-report and BIAGI did not differ and matched the lab results better than the Coeliac Dietary Adherence Test. Self-report and BIAGI were preferred for cost, time and accuracy. Not given as numbers in the abstract Methods, limits and fundingOutcomes: How well each tool matched laboratory results Limitations: This reviews how adherence is measured, not whether using a tool improves health. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Schmucker 2022 Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease Cochrane Database Syst Rev · PMID 35199850 · DOI |
Systematic review |
One randomised trial (60 people) and three cohort analyses (about 428,000 adults without celiac disease) | Lower-gluten or gluten-free diet · vs Higher gluten intake or usual diet |
The review excluded people with celiac disease. Low gluten intake was not linked with cardiovascular death (HR 1.00, CI 0.95 to 1.06) or heart attack (HR 0.99, CI 0.89 to 1.10), and may be linked with a slightly higher risk of type 2 diabetes (HR 1.14, CI 1.07 to 1.22), all low-certainty. Cardiovascular mortality HR 1.00 (0.95 to 1.06); type 2 diabetes HR 1.14 (1.07 to 1.22) Methods, limits and fundingOutcomes: Cardiovascular and metabolic outcomes in the general population Limitations: Mostly observational data; low or very low certainty; people who eat little gluten may differ in other ways. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Seiler 2020 Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Am J Gastroenterol · PMID 32740074 · DOI |
Systematic review meta analysis |
279 279 people with celiac disease in 6 randomised placebo-controlled trials |
Probiotics by mouth · vs Placebo |
Probiotics improved digestive symptoms when measured with the Gastrointestinal Symptom Rating Scale, but not when different questionnaires were pooled. Bifidobacteria rose. There was no difference in side effects. Data on quality of life were too thin to judge. GI Symptom Rating Scale: -28.7% (95% CI -43.96 to -13.52); Bifidobacteria +0.85 log CFU/g Methods, limits and fundingOutcomes: Digestive symptoms, quality of life, side effects, gut bacteria Limitations: The authors rate the certainty of evidence very low to low; small trials with different products. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Shiha 2024 Clinical outcomes of potential coeliac disease: a systematic review and meta-analysis Gut · PMID 39153845 · DOI |
Systematic review meta analysis |
1010 17 studies, 1,010 people with potential coeliac disease (positive blood and genetic markers, normal gut lining) |
Gluten-free diet or continuing gluten · vs Not compared |
About 33% of people with potential coeliac disease who kept eating gluten developed gut damage (villous atrophy) over follow-up, and 33% normalised their blood tests. Among those who followed a gluten-free diet, 88% reported symptom improvement. Symptom improvement on GFD 88% (95% CI 79% to 97%); progression 33% (CI 18% to 48%) Methods, limits and fundingOutcomes: Progression to gut damage and symptom response Limitations: Large differences between studies (I2 above 90%). Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Singh 2018 Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis Clin Gastroenterol Hepatol · PMID 29551598 · DOI |
Systematic review meta analysis |
275818 96 studies, blood-test data from 275,818 people |
Not an intervention study · vs Not an intervention study |
Pooled prevalence was 1.4% by antibody blood tests and 0.7% by biopsy-confirmed diagnosis. It was higher in females (0.6% vs 0.4%) and in children than adults (0.9% vs 0.5%). Blood-test 1.4% (CI 1.1 to 1.7); biopsy-confirmed 0.7% (CI 0.5 to 0.9) Methods, limits and fundingOutcomes: How common celiac disease is worldwide Limitations: Studies searched to 2016; the authors call for population studies in many countries. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| Yang 2026 Characteristics and clinical applicability of four dietary interventions for irritable bowel syndrome: A systematic review and meta-analysis Clin Nutr · PMID 42160924 · DOI |
Systematic review meta analysis |
939 10 randomised trials, 939 adults with irritable bowel syndrome |
Four dietary approaches, including a gluten-free diet · vs Other dietary interventions |
The low-FODMAP diet showed fairly consistent short-term benefit. The gluten-free diet showed inconsistent results and no clear advantage over other approaches. GFD vs comparators RR 1.19 (95% CI 0.83 to 1.70) Methods, limits and fundingOutcomes: Responder rates and symptom relief Limitations: Few trials; the abstract was read only to the point where it was cut off. Funding and conflicts: No funding or conflict statement in the record read. Read: abstract |
| s-nhs-dx NHS: Coeliac disease, diagnosis · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-nhs-overview NHS: Coeliac disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-nhs-tx NHS: Coeliac disease, treatment · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-def NIDDK: Definition & Facts for Celiac Disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-dx NIDDK: Diagnosis of Celiac Disease (last reviewed October 2020) · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-eat NIDDK: Eating, Diet, & Nutrition for Celiac Disease (last reviewed October 2020) · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-sym NIDDK: Symptoms & Causes of Celiac Disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-tx NIDDK: Treatment for Celiac Disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- No placebo-controlled trial of the gluten-free diet exists, so its high certainty rests on guidelines and consistent observational data.
- Only the abstracts of the 2025 European guidelines were read, not the full recommendations.
- No celiac-specific trial of a low-FODMAP diet was read.
- No herbal remedy for celiac disease was found in the sources read.
- Probiotic trials do not say which strains work.
- The NHS pages read did not show a review date.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Other 3
Celiac antibody blood tests (IgA anti-TG2)
Typically return to normal after treatment (NIDDK) in trials
Blood tests for antibodies that are usually raised in untreated celiac disease.
Moderate certaintyResults and what it means
Why it was measured
Used to help find celiac disease and, in follow-up, to see whether the diet is working.
Statistical vs. clinical meaning
Helpful in follow-up, but normal antibodies do not always mean the gut has healed, and some people with celiac disease do not have the antibodies (NHS).
| Study | Result | People | Product |
|---|---|---|---|
| 28 | Antibody levels are higher in untreated celiac disease but typically return to normal after treatment. | People with celiac disease on a gluten-free diet | Gluten-free diet |
Quality of life score (SF-36)
Rose on a gluten-free diet, but stayed below non-coeliac controls in trials
A questionnaire that scores physical and mental well-being.
Moderate certaintyResults and what it means
Why it was measured
Shows how people feel and function, not only what a biopsy shows.
Statistical vs. clinical meaning
A patient-centred measure; scores are self-reported.
| Study | Result | People | Product |
|---|---|---|---|
| 5 | Mental component +7.37 (CI 1.84 to 12.90) and physical +5.72 (CI 1.50 to 9.95) after starting the diet; treated adults were still 4.09 (mental) and 4.57 (physical) points below controls. | Adults with coeliac disease, 16 studies pooled | Gluten-free diet |
Bone mineral density (DXA scan)
Partly recovered by one year and fully by year five on a gluten-free diet in trials
A scan that measures how dense and strong the bones are.
Low certaintyResults and what it means
Why it was measured
Celiac disease can weaken bones through poor nutrient absorption; doctors may order a scan (NIDDK, NHS).
Statistical vs. clinical meaning
A direct measure of one complication; the data are observational.
| Study | Result | People | Product |
|---|---|---|---|
| 8 | Partial recovery of bone density by one year in all studies and full recovery by the fifth year. | Newly diagnosed adults in 20 studies | Gluten-free diet |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 6
- Get tested before you stop eating gluten. NIDDK and the NHS both say not to start a gluten-free diet before testing, because the diet can make the blood tests and biopsy inaccurate. Ask a doctor about testing first. If you already stopped gluten, ask your doctor what to do. Health agency guidance 25 21 26
- See a doctor for ongoing digestive symptoms, weight loss, anemia or a blistering rash. The NHS says to be tested if you have persistent unexplained digestive symptoms, constant tiredness, unintentional weight loss, severe or persistent mouth ulcers, unexplained iron, B12 or folate deficiency anaemia, type 1 diabetes, autoimmune thyroid disease, IBS, or a close relative with coeliac disease. An itchy, blistering rash (dermatitis herpetiformis) can occur with celiac disease. Health agency guidance 21 27
- Symptoms that continue on the diet need a clinician. NIDDK says about 20 percent of people with celiac disease have symptoms that continue or come back on a gluten-free diet. Causes include small amounts of hidden gluten, other health problems such as IBS, lactose intolerance, microscopic colitis, pancreas problems or bacterial overgrowth, and rarely refractory celiac disease. A 2024 review says continuing gluten exposure is the usual cause. Health agency guidance and review 28 11
- Hidden gluten in supplements, medicines and everyday products. NIDDK lists supplements, vitamins, lip products, toothpaste, mouthwash and, rarely, medicines as possible hidden sources of gluten, and says to ask a pharmacist about herbal and nutritional supplements and medicines. NIDDK adds that where gluten is in a medicine it is likely too little to cause symptoms. A scoping review found information and labelling about gluten in medicines varies widely between countries. Health agency guidance and scoping review 24 28 10
- Check labels and watch for cross-contact. In the US, foods labelled gluten-free must contain less than 20 parts per million of gluten, and the NHS gives the same limit for UK-labelled foods. The US rule does not apply to meat, poultry, some egg products and most alcoholic drinks. Cross-contact in growing, processing, storing, preparing or serving can make gluten-free food unsafe. Health agency guidance 26 23
- Mood, anxiety and eating problems. A meta-analysis of 37 articles found that people with coeliac disease have higher odds of depression, anxiety and eating disorders. The strict diet can add stress. If you are low, anxious or struggling with food, talk to your doctor; if you are in crisis or thinking of harming yourself, contact your local emergency services or crisis line right away. Systematic review 6
Side effects 3
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Gaps in fibre, vitamins and minerals, and extra sugar and fat from packaged gluten-free foods | Reported as common on long-term gluten-free diets; no rate in the abstract. | Not graded in the abstract | Narrative review and agency guidance 13 26 |
| Inaccurate celiac tests if gluten is stopped before testing | No rate given by the sources. | Can delay or prevent a correct diagnosis | Health agency guidance 25 21 |
| Possible slightly higher type 2 diabetes risk in cohort data on low gluten intake (general population) | HR 1.14 (CI 1.07 to 1.22), low certainty. | Not graded | Systematic review of cohort studies 16 |
Medicines and supplements 2
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Supplements, probiotics and medicines (gluten content) supplement | Some products contain gluten as a filler or additive. | NIDDK says to ask a pharmacist about the ingredients of herbal and nutritional supplements and of prescription and over-the-counter medicines; medicines are rare sources and the amount is usually too small to cause symptoms. | Health agency guidance Moderate certainty 28 24 | Check labels, ask a pharmacist, and ask the manufacturer if the label does not say. |
| Prescription medicines for celiac complications prescription | No study found. | No interaction study of the natural options with medicines used for celiac complications was read. Absence of a study is not proof of safety. | Absence of evidence Not enough evidence 28 | Tell your doctor or pharmacist about every supplement, probiotic or herbal product you use. |
Who should check first 5
| Situation | Advice | Evidence |
|---|---|---|
| Before testing for celiac disease | Do not remove gluten from your diet before testing unless a doctor tells you to; the diet can make tests inaccurate. | Health agency guidance 26 21 |
| Children and teens | Children with celiac disease need doctor and dietitian care for growth and development. NIDDK says symptoms such as short height and tooth defects may not improve if diagnosis comes late. Do not put a child on a gluten-free diet without testing. | Health agency guidance 27 22 |
| Pregnancy or trying to conceive | NIDDK lists reproductive problems among celiac disease symptoms and the NHS lists problems with pregnancy among complications of untreated disease. Talk to your doctor about diet, nutrients and testing before and during pregnancy. | Health agency guidance 27 22 |
| Refractory celiac disease or ongoing weight loss | This needs specialist care. Refractory celiac disease is rare and can cause malnutrition (NIDDK, 2024 review). | Health agency guidance and review 24 11 |
| Mental health conditions or a history of eating disorders | A strict diet can add stress. Ask your clinician for support alongside dietitian care. | Systematic review 6 |
Overdose, product quality and regulators
| Body | Action | Date |
|---|---|---|
| NIDDK (US National Institutes of Health) (United States) | Describes the gluten-free diet as the treatment, advises testing before changing the diet, notes the FDA gluten-free label limit of less than 20 parts per million, and says to ask a pharmacist about gluten in supplements and medicines. source | 2020-10 |
| NHS (England) (United Kingdom) | Lists who should be tested, says to keep eating gluten until the diagnosis is confirmed, recommends a lifelong gluten-free diet with dietitian referral and an annual review, and says food labelled gluten-free contains no more than 20 ppm. source | 2026-10-31 |
When to get medical help
- Severe belly pain, repeated vomiting, blood in the stool or signs of dehydration: get urgent medical care or call your local emergency number.
- Unintentional weight loss, constant tiredness or persistent diarrhea: see a doctor for testing before changing your diet.
- An itchy, blistering rash on elbows, knees, buttocks, back or scalp: see a doctor (possible dermatitis herpetiformis).
- Symptoms that continue or return despite a strict gluten-free diet: talk to your doctor or dietitian.
- Low mood, anxiety or thoughts of harming yourself: contact a doctor or your local emergency or crisis service right away.
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What is celiac disease?
NIDDK says celiac disease is a chronic digestive and immune disorder that damages the small intestine and is triggered by eating gluten, a protein in wheat, barley and rye. About 1 percent of people worldwide have it.
How is celiac disease different from wheat allergy and gluten sensitivity?
NIDDK says gluten sensitivity may cause similar symptoms but does not damage the small intestine, and wheat allergy is a food allergy with different symptoms that does not cause long-term gut damage.
What are the symptoms of celiac disease?
Why should I get tested before going gluten-free?
Can I be tested if I am already gluten-free?
How is celiac disease diagnosed?
What does established celiac care look like?
Do I have to avoid oats?
NIDDK says most people with celiac disease can safely eat moderate amounts of oats if they are gluten-free, because ordinary oats are often contaminated. A 2017 meta-analysis of 28 studies found no change in symptoms or biopsies (low-quality evidence). The NHS notes a few people may still react. Discuss with your doctor or dietitian.
Is non-celiac gluten sensitivity real?
Is a gluten-free diet healthier for everyone?
Can probiotics, enzymes or supplements replace the diet?
Explore by health goal
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-31
- Last substantive update
- 2026-10-31
- How we research
- We searched PubMed, read the abstract of every review and guideline cited, and read the NIDDK and NHS pages as plain text. Certainty ratings are the compiler's own reading unless a review gives its own grade.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown.
Sources 28
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Al-Toma A, Zingone F, Branchi F et al.. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach. United European Gastroenterol J. 2025. PMID 40999951. DOI 10.1002/ueg2.70119. (abstract)
- Al-Toma A, Branchi F, Zingone F et al.. European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses. United European Gastroenterol J. 2026. PMID 41831197. DOI 10.1002/ueg2.70195. (abstract)
- Bektaş A. Non-celiac Gluten Sensitivity: A New Clinical Entity or Growing Controversy?. Euroasian J Hepatogastroenterol. 2025. PMID 41757144. DOI 10.5005/jp-journals-10018-1479. (abstract)
- Biesiekierski JR. Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity. Best Pract Res Clin Gastroenterol. 2025. PMID 41423308. DOI 10.1016/j.bpg.2025.102086. (abstract)
- Burger JPW, de Brouwer B, IntHout J et al.. Systematic review with meta-analysis: Dietary adherence influences normalization of health-related quality of life in coeliac disease. Clin Nutr. 2017. PMID 27179800. DOI 10.1016/j.clnu.2016.04.021. (abstract)
- Clappison E, Hadjivassiliou M, Zis P. Psychiatric Manifestations of Coeliac Disease, a Systematic Review and Meta-Analysis. Nutrients. 2020. PMID 31947912. DOI 10.3390/nu12010142. (abstract)
- Girbal-González M, Pérez-Cano FJ. Is There a Future Without Gluten Restrictions for Celiac Patients? Update on Current Treatments. Nutrients. 2025. PMID 41010485. DOI 10.3390/nu17182960. (abstract)
- Grace-Farfaglia P. Bones of contention: bone mineral density recovery in celiac disease--a systematic review. Nutrients. 2015. PMID 25961322. DOI 10.3390/nu7053347. (abstract)
- Lacy BE, Pimentel M, Brenner DM et al.. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021. PMID 33315591. DOI 10.14309/ajg.0000000000001036. (abstract)
- Lizano-Díez I, Mariño EL, Modamio P. Gluten in pharmaceutical products: a scoping review. Syst Rev. 2021. PMID 34364399. DOI 10.1186/s13643-021-01772-9. (abstract)
- Malamut G, Soderquist CR, Bhagat G et al.. Advances in Nonresponsive and Refractory Celiac Disease. Gastroenterology. 2024. PMID 38556189. DOI 10.1053/j.gastro.2024.02.048. (abstract)
- Mozafarybazargany M, Khonsari M, Sokoty L et al.. The effects of probiotics on gastrointestinal symptoms and microbiota in patients with celiac disease: a systematic review and meta-analysis on clinical trials. Clin Exp Med. 2023. PMID 36609792. DOI 10.1007/s10238-022-00987-x. (abstract)
- Pinto-Sanchez MI, Blom JJ, Gibson PR et al.. Nutrition Assessment and Management in Celiac Disease. Gastroenterology. 2024. PMID 38593924. DOI 10.1053/j.gastro.2024.02.049. (abstract)
- Pinto-Sánchez MI, Causada-Calo N, Bercik P et al.. Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 2017. PMID 28431885. DOI 10.1053/j.gastro.2017.04.009. (abstract)
- Ribeiro CDS, Uenishi RH, Domingues ADS et al.. Gluten-Free Diet Adherence Tools for Individuals with Celiac Disease: A Systematic Review and Meta-Analysis of Tools Compared to Laboratory Tests. Nutrients. 2024. PMID 39125309. DOI 10.3390/nu16152428. (abstract)
- Schmucker C, Eisele-Metzger A, Meerpohl JJ et al.. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2022. PMID 35199850. DOI 10.1002/14651858.CD013556.pub2. (abstract)
- Seiler CL, Kiflen M, Stefanolo JP et al.. Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol. 2020. PMID 32740074. DOI 10.14309/ajg.0000000000000749. (abstract)
- Shiha MG, Schiepatti A, Maimaris S et al.. Clinical outcomes of potential coeliac disease: a systematic review and meta-analysis. Gut. 2024. PMID 39153845. DOI 10.1136/gutjnl-2024-333110. (abstract)
- Singh P, Arora A, Strand TA et al.. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018. PMID 29551598. DOI 10.1016/j.cgh.2017.06.037. (abstract)
- Yang X, Shui X. Characteristics and clinical applicability of four dietary interventions for irritable bowel syndrome: A systematic review and meta-analysis. Clin Nutr. 2026. PMID 42160924. DOI 10.1016/j.clnu.2026.106680. (abstract)
- . NHS: Coeliac disease, diagnosis. . . (full-text)
- . NHS: Coeliac disease. . . (full-text)
- . NHS: Coeliac disease, treatment. . . (full-text)
- . NIDDK: Definition & Facts for Celiac Disease. . . (full-text)
- . NIDDK: Diagnosis of Celiac Disease (last reviewed October 2020). . . (full-text)
- . NIDDK: Eating, Diet, & Nutrition for Celiac Disease (last reviewed October 2020). . . (full-text)
- . NIDDK: Symptoms & Causes of Celiac Disease. . . (full-text)
- . NIDDK: Treatment for Celiac Disease. . . (full-text)